论文部分内容阅读
翁心植,1919年5月10日生于浙江鄞县。1945年获华西协合大学医学博士学位,现任北京红十字朝阳医院教授,1997年当选为中国工程院院士。在长达半个多世纪的内科实践中,他对普通内科、寄生虫病、心血管病和呼吸系统病诸领域均有创造性贡献。70年代以来,翁心植在慢性阻塞性肺疾病和肺心病方面进行了大量的研究,使我国在这一领域达到国际水平。由于他率先发起了我国的控烟运动,被誉为“中国控烟第一人”和“中国反吸烟运动之祖”。提起翁心植院士,人们想的更多的也许并不是他在内科领域所作出的贡献,而是他在70年代末毅然发起控制吸烟(简称控烟)运动。作为我国最早提出控烟主张并为之奋斗不息的反烟斗士,翁院士为此殚精竭虑,不辞辛劳。在中国,禁卷烟始于翁心植翁心植教授长期从事冠心病、肺心病防治研究,深深体会到患者的痛苦,深感预防的重要。研究表明,我国的肺心病85%左右由于慢性支气管炎及肺气肿引起,而吸烟是慢性支气管炎的主要原因,也是冠心病的三大危害因素(高血压、高血脂及吸烟)之一。另据有关资料显示,我国是世界上最大的卷烟生产国和消费国。看到这些,翁教授再也坐不住了,看着一个个前来治疗的病人大多数是由吸烟引起的,翁教授心急如焚。1979年,翁心植下定决心将余生奉献给我国的控烟运动。
Weng Xinzhi, born May 10, 1919 in Zhejiang Yin County. In 1945 Huaxi Union University MD, the incumbent professor of Beijing Red Cross Chaoyang Hospital, elected in 1997 as the Chinese Academy of Engineering. In more than half a century of medical practice, he has made creative contributions to the fields of general medicine, parasitic diseases, cardiovascular diseases and respiratory diseases. Since the 1970s, Weng Xinzhi has done a great deal of research on chronic obstructive pulmonary disease and pulmonary heart disease, making our country reach the international standard in this field. As he took the lead in launching a tobacco control campaign in China, he is reputed as the “first person controlling tobacco in China” and the “ancestor of China’s anti-smoking campaign.” Mention Weng Xinzhi academicians, people think more may not be his contributions to the field of internal medicine, but he decided in the late 70s launched a tobacco control (tobacco control) campaign. As China’s first anti-tobacco warrior who proposed and kept fighting the tobacco control idea, Professor Weng worked tirelessly to this end. In China, the ban on cigarettes began with Professor Aung-woo Weng, a long time engaged in coronary heart disease, pulmonary heart disease prevention and treatment studies, deeply aware of the patient’s pain, the importance of prevention. Studies have shown that about 85% of our pulmonary heart disease is caused by chronic bronchitis and emphysema. Smoking is the main cause of chronic bronchitis and one of the three major risk factors of coronary heart disease (hypertension, hyperlipemia and smoking). According to relevant information, our country is the largest cigarette producer and consumer in the world. See these, Professor Weng can no longer sit still, looking at the treatment of patients one by one most of them caused by smoking, Professor Weng anxious. In 1979, Weng Xinzhi decided to dedicate the rest of his life to China’s tobacco control movement.